GeoVax is advancing development plans to evaluate Gedeptin in combination with checkpoint inhibitors, including pembrolizumab-based regimens, with the goal of amplifying anti-tumor immune activation ...

USA: A matched-cohort study found that patients with lung cancer, melanoma, or kidney cancer who received PCSK9 inhibitors ...

Once issued, this patent is expected to expire no earlier than September 2042. The allowed claims cover not only the combination of ibudilast with multiple anti-PD-1 antibodies, but also a broad range ...

Checkpoint inhibitors are antibody-based cancer therapies that unlock the immune system’s natural ability to fight cancer. These treatments work by blocking special proteins called immune checkpoints, ...

Skin cancers, lung cancers, lymphomas—though these cancers affect different parts of the body, they can all be treated with one of the latest therapies medicine has to offer: checkpoint inhibitors.

What if the trick to getting cancer immunotherapy to parts of the world that can’t access it is simply lowering the dose? A ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Inflammatory arthritis as a result of immune checkpoint cancer therapy remains a pressing ...

The median peak steroid dose was right at 20 mg (interquartile range 15-40), and the median aggregate dose over 6 months was ...

Research scientists found that a 'one-two punch' of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some cancers, ...

Researchers have discovered that activating the pentose phosphate pathway makes antitumor CD8+ T cells more likely to stay in an immature, stem-like, “precursor” state. Combining this metabolic ...

The medications most likely to cause thyroid eye disease are alemtuzumab, certain immune checkpoint inhibitors, amiodarone ...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally ...